IL11 and breast carcinoma: This observation, in addition to complementary in vitro and in vivo studies using IL-11 neutralizing antibodies and recombinant human IL-11, demonstrated that miR-124 induced downregulation of IL-11 is partially responsible for reduced breast cancer bone metastasis [46].